Bulletin
Sanofi’s JAK-2 Drug Kaput!
Farewell to Federatnib…we hardly knew ya’
In a stunning and unexpected announcement this morning, Sanofi pulled the plug on clinical trials and filings for its MF JAK-2 inhibitor SAR 302503(federatnib).
Here’s the text:
MPNforum Magazine 
Comments on: "Sanofi out of the JAK2-MF Biz" (2)
Of course you never want to a lose company whose developing drugs for a potnetial cure for MF.
This is a huge surpise I assume their drug did not work.